J. Coote

Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity.

R. Cowan, J. Logue, J. Livsey, 2009, International journal of radiation oncology, biology, physics.

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer

C. Faivre-Finn, G. Price, J. Kennedy, 2022, Frontiers in Oncology.

Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity.

V. Khoo, L. Perry, M. Saunders, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).

C. Faivre-Finn, G. Price, J. Kennedy, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?

C. Faivre-Finn, G. Price, J. Kennedy, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

R. Cowan, J. Logue, T. Elliott, 2012, Prostate cancer.

The use of volunteers to implement electronic patient reported outcomes in lung cancer outpatient clinics

C. Faivre-Finn, J. Yorke, D. Woolf, 2018, Technical innovations & patient support in radiation oncology.

118: Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)

C. Faivre-Finn, D. Woolf, N. Bayman, 2017 .

Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care

C. Faivre-Finn, F. Blackhall, J. Yorke, 2023, Journal of Patient-Reported Outcomes.

Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer.

C. Faivre-Finn, F. Blackhall, J. Yorke, 2023, JCO clinical cancer informatics.

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer

I. Fornacon-Wood, J. Coote, Raffaele Califano, 2024, Frontiers in oncology.